Statins and mortality in COPD in the COMIC study: A prospective COPD cohort study

Emanuel Citgez (Wierden, Netherlands), Emanuel Citgez, Job van der Palen, Paul van der Valk, Kirsten Koehorst-ter Huurne, Kris Movig, Marjolein Brusse-Keizer

Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Session: Novel avenues in the treatment of COPD II
Session type: Thematic Poster
Number: 4066
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Emanuel Citgez (Wierden, Netherlands), Emanuel Citgez, Job van der Palen, Paul van der Valk, Kirsten Koehorst-ter Huurne, Kris Movig, Marjolein Brusse-Keizer. Statins and mortality in COPD in the COMIC study: A prospective COPD cohort study. Eur Respir J 2016; 48: Suppl. 60, 4066

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
COPD and risk of cardiovascular disease: A prospective study of 0.5M Chinese adults
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Year: 2015

COPD and its comorbidities – prospective study
Source: Eur Respir J 2007; 30: Suppl. 51, 79s
Year: 2007

Five-repetition sit-to-stand and mortality in COPD: a prospective cohort study
Source: International Congress 2018 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2018



Measuring exacerbations in subjects with mild to moderate COPD from a population-based cohort: The CanCOLD study
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013


Efficacy and safety of erdosteine in COPD: Results of a 12-month prospective, multinational study
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015


Clinical characteristics of patients with frequent COPD exacerbations in a Swiss multicenter COPD cohort study (TOPDOCS)
Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care
Year: 2016


Predictors of long-term mortality after hospitalization for COPD; A Scandinavian multicentre study
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014

A prediction model for exacerbations in patients with COPD generated in a Swiss multicenter COPD cohort study (TOPDOCS)
Source: International Congress 2017 – Primary care management of asthma and COPD
Year: 2017


Co-morbidities of adult smokers at risk of COPD evaluated in a 6-year prospective study
Source: International Congress 2015 – COPD: notable points
Year: 2015


Risk of future exacerbations among COPD patients – a real-world register-based cohort study (AvoidEx)
Source: Virtual Congress 2020 – Airflow obstruction, COPD and comorbidities
Year: 2020




Tiotropium discontinuation in patients with early-stage COPD: a prospective observational cohort study
Source: ERJ Open Res, 5 (1) 00175-2018; 10.1183/23120541.00175-2018
Year: 2019



Risk factors of re-hospitalisation for a COPD exacerbation: a prospective study
Source: Eur Respir J 2002; 20: Suppl. 38, 402s
Year: 2002

Real-world exacerbation rates in Japanese patients with COPD: results from the EXACOS observational cohort study
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021


The OLIN COPD study – design and the first year‘s mortality
Source: Eur Respir J 2006; 28: Suppl. 50, 447s
Year: 2006

Characteristics of subjects susceptible to exacerbation-like respiratory events in a population-based cohort: Canadian cohort obstructive lung disease (CanCOLD) study
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014


GOLD classification of COPD and subsequent mortality: findings from a cohort study
Source: Annual Congress 2004 - Burden of obstructive lung diseases: costs, mortality and life impairment
Year: 2004


Interferon-lambda-genotype GG and IgG2 are predictors for frequent COPD exacerbations in a Swiss multicenter COPD cohort study (TOPDOCS)
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016


COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study
Source: International Congress 2014 – Markers
Year: 2014

Short-term HRQL deterioration during early-phase COPD exacerbation: a prospective Canadian cohort study
Source: Eur Respir J 2005; 26: Suppl. 49, 296s
Year: 2005

Costs and effects of structured COPD care – An observational, matched-cohort study
Source: Annual Congress 2013 –Early diagnosis and effectiveness of disease management in primary care
Year: 2013